Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model

Oxaliplatin, fluorouracil plus leucovorin (FOLFOX) regimen is the first-line chemotherapy of patients with metastatic colorectal cancer (mCRC). However, studies are limited regarding long non-coding RNAs (lncRNAs) associated with FOLFOX chemotherapy response and prognosis. This study aimed to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yiyi, Xu, Meifang, Sun, Yanwu, Chen, Ying, Chi, Pan, Xu, Zongbin, Lu, Xingrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876414/
https://www.ncbi.nlm.nih.gov/pubmed/33585448
http://dx.doi.org/10.3389/fcell.2020.609832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876414/
https://www.ncbi.nlm.nih.gov/pubmed/33585448
http://dx.doi.org/10.3389/fcell.2020.609832

Ejemplares similares